MBHB Partner Kevin Noonan Authors PharmaLetter Article Entitled, “FDA seeks to accelerate pace of biosimilar drug approvals”
October 4, 2018
McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authored an October 4, 2018 PharmaLetter article entitled, “FDA seeks to accelerate pace of biosimilar drug approvals.” view the article
